Murine marrow-derived mesenchymal stem cell:: isolation, in vitro expansion, and characterization

被引:361
作者
Meirelles, LD [1 ]
Nardi, NB [1 ]
机构
[1] Univ Fed Rio Grande do Sul, Dept Genet, Lab Imunogenet, Porto Alegre, RS, Brazil
关键词
mesenchymal stem cell; fibroblast colony-forming unit; bone marrow; mouse; in vitro cultivation;
D O I
10.1046/j.1365-2141.2003.04669.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In spite of the attention given to the study of mesenchymal stem cells (MSCs) derived from the bone marrow (BM) of humans and other species, there is a lack of information about murine MSCs. We describe the establishment of conditions for the in vitro expansion of plastic-adherent cells from murine BM for over 50 passages, and provide their characterization regarding morphology, surface marker profile and growth kinetics. These cells were shown to differentiate along osteogenic and adipogenic pathways, and to support the growth and differentiation of haematopoietic stem cells, and were thus operationally defined as murine mesenchymal stem cells (mMSCs). mMSCs were positive for the surface markers CD44, CD49e, CD29 and Sca-1, and exhibited a homogeneous, distinctive morphology. Their frequency in the BM of adult BALB/c and C57Bl/6 mice, normal or knockout for the alpha-L-iduronidase (IDUA) gene, was preliminarily estimated to be 1 per 11 300-27 000 nucleated cells. The emergence of a defined methodology for the culture of mMSCs, as well as a comprehensive understanding of their biology, will make the development of cellular and genetic therapy protocols in murine models possible, and provide new perspectives in the field of adult stem cells research.
引用
收藏
页码:702 / 711
页数:10
相关论文
共 38 条
[1]   Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection [J].
Baddoo, M ;
Hill, K ;
Wilkinson, R ;
Gaupp, D ;
Hughes, C ;
Kopen, GC ;
Phinney, DG .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 89 (06) :1235-1249
[2]   Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy [J].
Banfi, A ;
Muraglia, A ;
Dozin, B ;
Mastrogiacomo, M ;
Cancedda, R ;
Quarto, R .
EXPERIMENTAL HEMATOLOGY, 2000, 28 (06) :707-715
[3]  
CASTROMALASPINA H, 1980, BLOOD, V56, P289
[4]   Comparative study of stromal cell lines derived from embryonic, fetal, and postnatal mouse blood-forming tissues [J].
Charbord, P ;
Oostendorp, R ;
Pang, WX ;
Hérault, O ;
Noel, F ;
Tsuji, T ;
Dzierzak, E ;
Péault, B .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (10) :1202-1210
[5]   Murine mucopolysaccharidosis type I: Targeted disruption of the murine alpha-L-iduronidase gene [J].
Clarke, LA ;
Russell, CS ;
Pownall, S ;
Warrington, CL ;
Borowski, A ;
Dimmick, JE ;
Toone, J ;
Jirik, FR .
HUMAN MOLECULAR GENETICS, 1997, 6 (04) :503-511
[6]   Mesenchymal stem cells: Biology and potential clinical uses [J].
Deans, RJ ;
Moseley, AB .
EXPERIMENTAL HEMATOLOGY, 2000, 28 (08) :875-884
[7]   Immortalized multipotential mesenchymal cells and the hematopoietic microenvironment [J].
Dormady, SP ;
Bashayan, O ;
Dougherty, R ;
Zhang, XM ;
Basch, RS .
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2001, 10 (01) :125-140
[8]  
FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267
[9]  
Haynesworth SE, 1996, J CELL PHYSIOL, V166, P585, DOI 10.1002/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.3.CO
[10]  
2-7